{
    "nctId": "NCT05666258",
    "briefTitle": "Gene Expression Profiling to Help Define the Need for Neo-Adjuvant Chemotherapy in HR+, HER- Breast Cancer Patients",
    "officialTitle": "Gene Expression Profiling to Help Define the Need for Neo-Adjuvant Chemotherapy in HR+, HER- Breast Cancer Patients",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 20,
    "primaryOutcomeMeasure": "De-escalation of breast cancer surgery",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Tumour characteristics: HR+, HER-\n* Histopathological tumour characteristics: cT1-3, cN1, cM0, all histological types included\n* Age: 18-85 years\n\nExclusion Criteria:\n\n* Tumour characteristics: cT4, cN2-3, cM1\n* Age: \\<18 or \\>85 years old\n* Received chemotherapy in the last 5 years\n* Pregnancy",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}